Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
455.1 USD | +0.96% | +2.18% | +11.80% |
May. 22 | Vertex Pharmaceuticals Insider Sold Shares Worth $6,795,294, According to a Recent SEC Filing | MT |
May. 21 | ADDvise Group’s Axelerist Bags $1.4 Million Order for Medical, Lab Equipment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.80% | 116B | |
+12.42% | 106B | |
-7.45% | 23.89B | |
-2.65% | 21.58B | |
-10.72% | 18.96B | |
-40.50% | 16.96B | |
-13.71% | 16.33B | |
+6.98% | 14.14B | |
+33.42% | 12.02B | |
-2.10% | 7.58B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Goldman Sachs Adjusts Vertex Pharmaceuticals' Price Target to $578 From $559, Keeps Buy Rating